热线电话:+86 512 6799 8818

在线咨询

TOP

*姓名

*电话

邮箱

咨询内容

*验证码

联系销售


Sales Image

联系销售助理


Sales Assistant Image

联系PM


PM Image
GentleGen Frontier Focus: By 2026, sgRNA will evolve from a "navigator" to an "operating system" for gene editing.
Release time:2026-08-10
Share:

If CRISPR-Cas9 is a gene "scissors," then sgRNA (single-stranded guide RNA) is the "navigator" of this scissors—it determines where the scissors should be cut in the genome. Without sgRNA, Cas9 protein is like a drone without GPS, struggling to move through a genome of 3 billion base pairs.

 

In 2026, sgRNA is undergoing a profound transformation. This transformation has two dimensions: one is making navigation more precise and powerful—multiple sgRNA collaborative combat and fully armed with chemical modifications; Another dimension is a complete overhaul of the understanding of the navigator itself—the TDO mechanism reveals new sources of off-target detection, ΨDNA breaks the dogma that "the guide must be RNA," and time control strategies make large-scale screening more efficient. Both advances point to one conclusion: sgRNA is becoming the core control layer of the entire gene editing system.

 

Evolution: Making navigation more precise and powerful

  • Multiple sgRNA: Quadruple firepower, precise strikes

The cleavage efficiency of a single sgRNA is often significantly reduced due to poor target accessibility and chromatin status. A study published in Nature Communications in 2026 proposed a simple and effective solution: using four sgRNAs to simultaneously target one gene.

 

Screenshot _7-7-2026_101913_www.nature.com

 

Multiple sgRNAs operate through a dual mechanism of redundancy and synergy: even if one fails, the others can still be replaced, and large fragment deletions frequently occur between cleavage sites, significantly increasing the proportion of complete gene inactivation. The study evaluated the activity of over 2,000 sgRNAs in 33% of the Drosophila genome, achieving targeting efficiency exceeding 99%, an off-target rate below 1%, outperforming the Cas9 system in parallel comparisons with over 100 genes, and identifying phenotypes missed by traditional methods, providing an efficient and reliable new tool for large-scale functional genomics screening.

 

  • Chemically modified sgRNA: Fully armed with guide RNA

Natural sgRNA is easily degraded by nuclease enzymes in the body, severely limiting the application of CRISPR in vivo.

 

The research team systematically introduced various chemical modifications to obtain gRNA with over 90% nucleotide modification. Although some modification patterns exhibit sequence-dependent activity differences, the team has established an expanding library of highly modified gRNAs that maintain or even enhance editing efficiency both in vitro and in vivo, clearing key bottlenecks for in vivo delivery and therapeutic applications of CRISPR.

 

Revolution: Revolutionizing the understanding of navigation devices
  • Discovery of TDO off-target mechanism: sgRNA backbone can also be 'harmed'

The traditional view holds that the off-target effect of CRISPR mainly arises from sequence mismatches between sgRNA and genomic DNA, but a team at the Shanghai Institute of Biomedical Technology discovered a novel mechanism:

 

Screenshot_9-7-2026_101055_www.sibpt.cn

 

Endogenous RNA can repair with exogenous tracrRNA to form a functional guide RNA complex, mediating low-frequency broad off-target in Cas9, named TDO. There are many potential TDO loci in the human transcriptome, and traditional assessment systems may seriously underestimate the risk of off-target. Based on this, the team built a library of nearly 6,000 gRNA skeleton libraries, combined machine learning to analyze pairing patterns, and developed a segRNA platform that combines high security with versatility.

 

  • DNA as a Guide: ΨDNA Revolutionizes CRISPR's "RNA Dependence"

If the discovery of TDO was a warning that "RNA wizards might be hijacked," then in May 2026, Nature Biotechnology offered a more thorough solution: replacing RNA with DNA.

 

Screenshot _9-7-2026_102338_www.nature.com

 

The ψdna system uses DNA as its framework to guide Cas12 in recognizing RNA targets, offering greater stability and lower synthesis costs, with a clinical detection accuracy of 100%. In cells, this system achieves 70-95% of endogenous RNA knockdown efficiency in various human cell lines, and moreover Both off-target effect and cytotoxicity are lower than those of the traditional Cas13 system, completely breaking the doctrine that "the guide must be RNA."

 

Screenshot _9-7-2026_102526_www.nature.com

 

  • Time control for sgRNA libraries: using fewer animals for larger screening

In vivo CRISPR screening typically requires a large number of animals to ensure the representativeness of the sgRNA library. On June 1, 2026, Cell Reports Methods reported on the CRISPR-StAR system—an induceable hybrid screening system that activates gene knockout only after tumor transplantation and provides matched internal controls. Using barcode embedding sequencing and Bayesian analysis workflows, the team screened 30,000 sgRNA libraries from only about 30 tumors, reducing animal usage by up to seven times compared to traditional in vivo screening. This technology makes large-scale in vivo CRISPR screening more feasible and ethically compliant.

 

1-s2.0-S2667237526001700-ga1_lrg

 

GentleGen provides one-stop gRNA library services

GentleGen has built a gene service technology platform integrating automation and intelligence, embedding an integrated link between gene synthesis, oligonucleotide synthesis, high-throughput sequencing, and gene editing services, providing a truly standardized, highly precise, and cost-effective one-stop solution for CRISPR sgRNA library construction and screening.

 

  • Ultra-high synthesis accuracy ensures every sgRNA is precisely positioned

Relying on its self-developed oligonucleotide synthesis platform, GentleGen has achieved an ultimate mutation rate of 1‰ in oligonucleotide synthesis—meaning that for critical sequence lengths, GentleGen can ensure that over 90.5% of sgRNA sequences perfectly match theoretical designs, guaranteeing precise targeting of every gRNA from the sequence source!

 

  • Coverage ≥99%, uniformity <10, using data to define the standards for high-quality libraries

Coverage and homogeneity are the "golden dual cores" for evaluating document quality. Under a strict quality control system, GentleGen delivers over 99% library coverage to clients, while maintaining an industry-leading level of uniformity below 10.

 

  • High-standard quality control + NGS deep sequencing verification, data speaks for itself at a glance

Once the library is built, it is not simply a matter of packaging and shipping. GentleGen independently validates every delivered plasmid library strictly according to NGS sequencing depth ≥300×, delivering high-purity, endotoxin-free plasmids (total ≥ 200μg), allowing you to control quality during the "first mile" of experiments without extra effort.

 

  • A path just for you, with customizable personalized library solutions

There are many directions for basic research or drug development. For whole-genome exploration, GentleGen can directly provide standardized human and mouse whole-genome knockout libraries to support large-scale genetic screening efforts. For specific needs for precisely targeting specific signaling pathways or target gene sets, GentleGen's customized services are always on standby, tailoring and synthesizing each client's unique targets.

 

  • From screening to validation, chain-based delivery enables closed loops to arrive faster

Relying on strong NGS bioanalytical capabilities and long-term gene editing experience, GentleGen is not limited to library plasmid construction—from lentiviral packaging, cell infection, screening pressure application, to final high-throughput sequencing and data analysis, GentleGen can scientifically and reasonably integrate generations, helping researchers shorten project cycles, quickly lock onto "targets," and achieve a complete validation closed loop.

 

GentleGen offers a one-stop sgRNA library service with high precision, high efficiency, and high cost-performance, defined precisely by standards! GentleGen can provide related services. For more details about related services, please send an email to marketing@gentlegen.com.

Pre-sales consulting

Pre-sales consulting

A more reliable solution for your needs.
Download

Download

Welcome to our product library.
Sales network

Sales network

Complete sales and service network to ensure product quality.
Event Promotions

Event Promotions

Add to cart now and enjoy this shopping extravaganza!